Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
PaperCitations, authors & open-access status
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 339 citations, 2019 year and hybrid oa status.
339
Citations
2019
Year
hybrid
OA Status